FUNCTIONAL EFFECTS OF CARDIOMYOPATHIC MYOSIN MUTATIONS
心肌病肌球蛋白突变的功能影响
基本信息
- 批准号:6167275
- 负责人:
- 金额:$ 8.84万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1995
- 资助国家:美国
- 起止时间:1995-05-15 至 2001-04-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION:
This project is aimed at defining the functional deficits resulting from
cardiac myosin mutations that cause hypertrophic cardiomyopathy (HCM).
Experiments will be carried out on human slow skeletal muscle fibers
obtained from biopsies from normal and HCM patients, as well as on
cultured quail myotubes transfected with human cardiac myosin heavy
chains. The central hypothesis is that the mutant myosin in HCM has
impaired function. Dr. Lankford will use molecular techniques to create
mutant human myosin heavy chain constructs that will be expressed in
quail myogenic cell cultures. Some of the mutant myosins to be
constructed will resemble the naturally occurring mutant myosins found
in patients with HCM, while others will have different mutations.
Mechanical studies will be performed on isolated myotubes from these
cultures to allow quantification of the performance of mutated myosin.
The applicant will also study skeletal muscle biopsies from humans with
HCM. These studies in these two different systems will allow an
increased understanding of the process of force generation by actin-
myosin interaction, and the structure/function relationship in the
myosin heavy chain. The studies will be performed in the laboratory of
Dr. Lee Sweeney, an assistant professor, with consultation with Dr.
Judith L. Swain, an internationally recognized leader in the field of
muscle biology.
描述:
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
EDWARD B LANKFORD其他文献
EDWARD B LANKFORD的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('EDWARD B LANKFORD', 18)}}的其他基金
Mechanism of Ethanol's Cardiac Inotropic Depression
乙醇抑制心脏正性肌力的机制
- 批准号:
6471932 - 财政年份:2002
- 资助金额:
$ 8.84万 - 项目类别:
Mechanism of Ethanol's Cardiac Inotropic Depression
乙醇抑制心脏正性肌力的机制
- 批准号:
6744712 - 财政年份:2002
- 资助金额:
$ 8.84万 - 项目类别:
Mechanism of Ethanol's Cardiac Inotropic Depression
乙醇抑制心脏正性肌力的机制
- 批准号:
6624025 - 财政年份:2002
- 资助金额:
$ 8.84万 - 项目类别:
FUNCTION OF MUTANT MYOSIN IN HYPERTROPHIC CARDIOMYOPATHY
突变肌球蛋白在肥厚性心肌病中的功能
- 批准号:
2213929 - 财政年份:1996
- 资助金额:
$ 8.84万 - 项目类别:
FUNCTIONAL EFFECTS OF CARDIOMYOPATHIC MYOSIN MUTATIONS
心肌病肌球蛋白突变的功能影响
- 批准号:
2211266 - 财政年份:1995
- 资助金额:
$ 8.84万 - 项目类别:
FUNCTIONAL EFFECTS OF CARDIOMYOPATHIC MYOSIN MUTATIONS
心肌病肌球蛋白突变的功能影响
- 批准号:
2910471 - 财政年份:1995
- 资助金额:
$ 8.84万 - 项目类别:
FUNCTIONAL EFFECTS OF CARDIOMYOPATHIC MYOSIN MUTATIONS
心肌病肌球蛋白突变的功能影响
- 批准号:
2211265 - 财政年份:1995
- 资助金额:
$ 8.84万 - 项目类别:
FUNCTIONAL EFFECTS OF CARDIOMYOPATHIC MYOSIN MUTATIONS
心肌病肌球蛋白突变的功能影响
- 批准号:
2702076 - 财政年份:1995
- 资助金额:
$ 8.84万 - 项目类别:
FUNCTIONAL EFFECTS OF CARDIOMYOPATHIC MYOSIN MUTATIONS
心肌病肌球蛋白突变的功能影响
- 批准号:
2415467 - 财政年份:1995
- 资助金额:
$ 8.84万 - 项目类别:
相似海外基金
The mechanism of oral carcinogenesis by FAT1 gene mutation
FAT1基因突变导致口腔癌的机制
- 批准号:
23K15977 - 财政年份:2023
- 资助金额:
$ 8.84万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Development of an efficient method combining quantum chemistry and machine learning to evolve PCR technology and gene mutation analysis
开发一种结合量子化学和机器学习的有效方法来发展 PCR 技术和基因突变分析
- 批准号:
22KJ2450 - 财政年份:2023
- 资助金额:
$ 8.84万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Development of preemptive medicine for asymptomatic MEN1 gene mutation carriers
无症状MEN1基因突变携带者的抢先治疗药物开发
- 批准号:
23H03151 - 财政年份:2023
- 资助金额:
$ 8.84万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Elucidation of molecular mechanisms of occurrence of anaplastic thyroid cancer using gene mutation analysis and comprehensive gene expression analysis
利用基因突变分析和综合基因表达分析阐明甲状腺未分化癌发生的分子机制
- 批准号:
23K08067 - 财政年份:2023
- 资助金额:
$ 8.84万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Elucidation of the molecular mechanism of maxillofacial hypoplasia caused by FAT1 gene mutation
FAT1基因突变引起颌面发育不全的分子机制阐明
- 批准号:
22K19629 - 财政年份:2022
- 资助金额:
$ 8.84万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Association between CD79B gene mutation and prognosis in vitreoretinal lymphoma
CD79B基因突变与玻璃体视网膜淋巴瘤预后的关系
- 批准号:
22K09763 - 财政年份:2022
- 资助金额:
$ 8.84万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Gene mutation/expression prediction from clinical images using artificial intelligence technology in pancreatic cancer
利用人工智能技术从临床图像预测胰腺癌基因突变/表达
- 批准号:
20K17570 - 财政年份:2020
- 资助金额:
$ 8.84万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of colorectal carcinogenesis mediated by PTPRK gene mutation
PTPRK基因突变介导的结直肠癌发生机制的阐明
- 批准号:
20K16311 - 财政年份:2020
- 资助金额:
$ 8.84万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the molecular mechanism of development of anaplastic thyroid cancer using gene mutation analysis and comprehensive gene expression analysis
利用基因突变分析和综合基因表达分析阐明甲状腺未分化癌发生的分子机制
- 批准号:
20K08953 - 财政年份:2020
- 资助金额:
$ 8.84万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of next-generation precision medicine targeting the pathways on which driver gene mutation-positive lung cancer depends
针对驱动基因突变阳性肺癌所依赖的途径开发下一代精准医疗
- 批准号:
20H03771 - 财政年份:2020
- 资助金额:
$ 8.84万 - 项目类别:
Grant-in-Aid for Scientific Research (B)